Table-IV.

Outcomes of patients with HBV-DNA increases after treatment.

Disease course	Age(year)	Gender	HBsAg	Baseline HBV-DNA (copies/mL)	After
					HBV-DNA (copies/mL)	AST (U/L)	ALT (U/L)	Liver state
1	42	Female	Positive	<1.0×103	1.93×103	29	39	Asymptomatic HBV-DNA increase
2	39	Female	Positive	<1.0×103	7.88×103	29	37	Asymptomatic HBV-DNA increase
3	55	Female	Positive	<1.0×103	4.0×103	116	124	HBV-DNA increase, jaundice-free hepatitis
4	53	Male	Positive	<1.0×103	7.66×105	29	21	Asymptomatic HBV-DNA reactivation
5	29	Female	Positive	7.14×103	9.92×105	48	104	HBV reactivation, jaundice-free hepatitis
6	53	Female	Positive	<1.0×103	9.66×105	327	741	HBV reactivation, jaundice-free hepatitis
7	58	Female	Positive	<1.0×103	1.04×105	327	202	HBV reactivation, jaundice-accompanied hepatitis
8	17	Female	Positive	3.29×105	1.79×108	834	826	HBV reactivation, jaundice-accompanied hepatitis